Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
ERK1/2-Akt1 crosstalk regulates arteriogenesis in mice and zebrafish
Bin Ren, … , Randall T. Peterson, Michael Simons
Bin Ren, … , Randall T. Peterson, Michael Simons
Published March 8, 2010
Citation Information: J Clin Invest. 2010;120(4):1217-1228. https://doi.org/10.1172/JCI39837.
View: Text | PDF
Research Article Vascular biology

ERK1/2-Akt1 crosstalk regulates arteriogenesis in mice and zebrafish

  • Text
  • PDF
Abstract

Arterial morphogenesis is an important and poorly understood process. In particular, the signaling events controlling arterial formation have not been established. We evaluated whether alterations in the balance between ERK1/2 and PI3K signaling pathways could stimulate arterial formation in the setting of defective arterial morphogenesis in mice and zebrafish. Increased ERK1/2 activity in mouse ECs with reduced VEGF responsiveness was achieved in vitro and in vivo by downregulating PI3K activity, suppressing Akt1 but not Akt2 expression, or introducing a constitutively active ERK1/2 construct. Such restoration of ERK1/2 activation was sufficient to restore impaired arterial development and branching morphogenesis in synectin-deficient mice and synectin-knockdown zebrafish. The same approach effectively stimulated arterial growth in adult mice, restoring arteriogenesis in mice lacking synectin and in atherosclerotic mice lacking both LDL-R and ApoB48. We therefore conclude that PI3K-ERK1/2 crosstalk plays a key role in the regulation of arterial growth and that the augmentation of ERK signaling via suppression of the PI3K signaling pathway can effectively stimulate arteriogenesis.

Authors

Bin Ren, Yong Deng, Arpita Mukhopadhyay, Anthony A. Lanahan, Zhen W. Zhuang, Karen L. Moodie, Mary Jo Mulligan-Kehoe, Tatiana V. Byzova, Randall T. Peterson, Michael Simons

×

Figure 1

PI3K suppression activates ERK signaling in synectin-deficient AECs and in zebrafish.

Options: View larger image (or click on image) Download as PowerPoint
PI3K suppression activates ERK signaling in synectin-deficient AECs and ...
(A–E) Western blots of AECs from WT and synectin-null mice after treatment with VEGF-A165 in vitro. (A) Activation of the VEGFR2 Y1175 site by VEGF-A. Data shown are for 10 minutes after VEGF stimulation. T-, total. (B) Time course of ERK activation after VEGF-A165 treatment. Note reduced ERK activation in synectin-deficient AECs. (C) Time course of Akt activation after VEGF-A165 treatment. Note reduced AKT activation in synectin-deficient AECs. (D) Restoration of ERK activation by PI3K inhibition. Synectin-deficient AECs were stimulated with VEGF-A in the presence of increasing concentrations of LY294002 or GS4898, and ERK activation was tested 10 minutes later. Note dose-dependent increase in ERK activation. (E) Time course of ERK activation in synectin-deficient AECs by PI3K inhibition. Note long-term restoration of activity. (F and G) Analysis of P-ERK1/2 and total ERK1/2 expression in zebrafish embryos. At 1-ss, embryos were injected with 12 ng anti-synectin MOs or left untreated (NT). At 8-ss, injected embryos were treated with 20, 50, or 100 μM GS4898 or DMSO as a control. (F) Representative Western blot. (G) Quantitative analysis of P-ERK/T-ERK ratio.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts